Epidemiological and Genetic Characteristics of Sapovirus in Shandong, China, 2022–2023
Viruses · 2025
DOI: 10.3390/v17040469 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Mingxin Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Health Management, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan 250117, China. Hauptthemen laut MEDLINE: Sapovirus, Caliciviridae Infections, Gastroenteritis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Sapovirus (SaV) is a major pathogen responsible for acute gastroenteritis (AGE), and its incidence has been increasing in recent years. This study investigates the prevalence and the genetic characteristics of SaV in Shandong Province during 2022–2023, based on a surveillance network covering all age groups. Samples were obtained from a viral diarrhea surveillance network in Shandong Province during 2022–2023. SaVs were identified through quantitative reverse-transcription polymerase chain reaction (RT-qPCR). PCR amplification and Sanger sequencing were performed on positive samples, and whole-genome sequencing was conducted using metagenomic sequencing technology. Sequence analysis was conducted using BioEdit 7.0.9.0 and MEGA X, while statistical analysis was performed with SPSS 26.0. A total of 157 SaV-positive cases were identified, resulting in a positivity rate of 1.12%. The positivity rate for SaV was 0.75% in 2022 and it increased significantly to 1.42% in 2023. The highest positivity rates for both 2022 and 2023 were observed in November. The highest positivity rate was observed in the 3–5-year-old age group. In 2022, Dongying City had the highest positivity rate, while Zaozhuang City exhibited the highest rate in 2023. The incidence of vomiting in SaV-positive patients was significantly higher compared to SaV-negative patients (P = 0.002). Eight genotypes were identified in both the VP1 and RdRp regions. The complete genome sequence analysis of a GI.3 strain showed that NS1 (5.88%, 4/68) was the region most prone to amino acid variation, followed by VP2 (5.45%, 9/165) within the same genotype. SaV infections are more prevalent in cold weather, with young children being particularly susceptible. The SaV positivity rate in 2023 increased significantly accompanied by an increased diversity of genotypes, compared to that of 2022. The NS1 region exhibits the biggest variation within the same genotype, indicating that more attention should be paid to other regions besides VP1 in the future study. Ongoing surveillance of SaV is recommended for effective prevention and control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health and Health Management, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan 250117, China.
- Shandong Provincial Center for Disease Control and Prevention, Jinan 250014, China.
- Shandong Provincial Key Laboratory of Intelligent Monitoring, Early Warning, Prevention and Control for Infectious Diseases, Jinan 250014, China.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Guo, M., Li, M., Liu, T., Sun, W., Du, K., Yang, S., Fu, Z., & Kou, Z. (2025). Epidemiological and Genetic Characteristics of Sapovirus in Shandong, China, 2022–2023. Viruses. https://doi.org/10.3390/v17040469
Vancouver
Guo M, Li M, Liu T, Sun W, Du K, Yang S, et al. Epidemiological and Genetic Characteristics of Sapovirus in Shandong, China, 2022–2023. Viruses. 2025. doi:10.3390/v17040469
BibTeX
@article{Guo2025,
author = {Guo, Mingxin and Li, Meijia and Liu, Ti and Sun, Wenkui and Du, Kaige and Yang, Shuopeng and Fu, Zhongyan and Kou, Zengqiang},
title = {Epidemiological and Genetic Characteristics of Sapovirus in Shandong, China, 2022–2023},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17040469}
}
EUVIMED